Related Experiment Videos
Papillary cystadenocarcinoma of the sublingual gland presenting as a ranula
M Danford1, J W Eveson, T R Flood
1Wessex Centre for Plastic and Maxillofacial Surgery, Salisbury.
The British Journal of Oral & Maxillofacial Surgery
|August 1, 1992
Abstract:
A case is reported of a papillary cystadenocarcinoma of the sublingual gland which presented as a ranula. This is both rare in site and mode of presentation.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oral L-menthol reduces thermal sensation, increases work-rate and extends time to exhaustion, in the heat at a fixed rating of perceived exertion.
European journal of applied physiology·2017
An orbital apex fracture resulting in multiple cranial neuropathies.
The British journal of oral & maxillofacial surgery·2007
Radiographic predictors for the absence of pain in disc displacement with and without reduction.
The British journal of oral & maxillofacial surgery·2026
Online patient information on elective orthognathic surgery provided by UK National Health Services hospitals: assessment of readability and improvement using large language models.
The British journal of oral & maxillofacial surgery·2026
Risk factors associated with complications in surgical treatment of mandibular fractures: a retrospective study.
The British journal of oral & maxillofacial surgery·2026
Comparative effectiveness of one versus two miniplates in the management of mandibular angle fractures: a systematic review and meta-analysis.
The British journal of oral & maxillofacial surgery·2026
PEEK patient-specific implants for orbital reconstruction: accuracy and clinical outcomes.
The British journal of oral & maxillofacial surgery·2026
Effectiveness of intraoperative radiography in zygomatic fracture management: a systematic review and meta-analysis.
The British journal of oral & maxillofacial surgery·2026
Histopathologic Features of an Attenuated Onychomatricoma: A Novel Variant.
Journal of cutaneous pathology·2026
Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II-III Lung Adenocarcinoma: A Multicenter CReGYT-03 ALK Study.
Annals of surgical oncology·2026